Palvella Therapeutics, Inc
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.79 | 1.05 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.60 | – | -0.02 | – | – | – | – | – | – | – | – | – | – | |
| 15.19 | 1.05 | – | – | – | – | – | – | – | – | – | – | – | |
| 7.76 | 3.60 | 0.78 | 1.11 | 2.42 | 1.14 | 1.83 | 0.46 | 0.59 | 0.63 | 0.71 | 0.87 | 2.47 | |
| – | – | 0.61 | 1.13 | 1.42 | 0.82 | 1.71 | 0.37 | 0.33 | 0.37 | 0.42 | 0.62 | 1.55 | |
| 12.70 | 5.48 | 1.39 | 2.25 | 3.83 | 1.96 | 3.54 | 0.84 | 0.92 | 1.00 | 1.14 | 1.49 | 4.02 | |
| 2.50 | -4.43 | -1.39 | -2.25 | -3.83 | -1.96 | -3.54 | -0.84 | -0.92 | -1.00 | -1.14 | -1.49 | -4.02 | |
| – | – | 0.63 | 0.82 | 0.94 | 0.59 | 0.55 | 0.12 | 0.14 | 0.15 | 0.16 | 0.16 | 0.53 | |
| -8.70 | -3.71 | -2.00 | -3.22 | -5.13 | -1.77 | -3.68 | -0.86 | -1.03 | -1.13 | -1.20 | -1.52 | -4.30 | |
| -8.70 | -3.71 | -2.00 | -3.22 | -5.13 | -1.77 | -3.68 | -0.86 | -1.03 | -1.13 | -1.20 | -1.52 | -4.30 | |
| -8.10 | -3.71 | -1.37 | -2.41 | -1.30 | -1.19 | -3.13 | -0.73 | 0.03 | -0.98 | -1.36 | -1.50 | -3.48 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.